Viewing Study NCT00881634


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-26 @ 6:44 PM
Study NCT ID: NCT00881634
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2009-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
Sponsor: Sandoz
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-06
Start Date Type: None
Primary Completion Date: 2005-07
Primary Completion Date Type: ACTUAL
Completion Date: 2005-07
Completion Date Type: ACTUAL
First Submit Date: 2009-04-13
First Submit QC Date: None
Study First Post Date: 2009-04-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-03-27
Last Update Post Date: 2017-03-28
Last Update Post Date Type: ACTUAL